A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Clinical trial NCT01343277 · COMPLETED
Trial details
- NCT number
- NCT01343277
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-01-01
- Enrollment
- 579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.